Monday, November 4, 2024
HomeTagsIDose TR

iDose TR

Glaukos Announces FDA Acceptance of NDA Submission for iDose TR

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced...

Celanese Announces Agreement with Glaukos Corporation for Sustained Release Glaucoma Treatment

Celanese Corporation, a global specialty materials and chemical company, announced that it has entered into an agreement with Glaukos Corporation to supply its VitalDose Drug...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics